Funding
← Back to your selection

CE-Ventures

Activity from announced rounds

Activity in this selectioncadence-161c8a37

CE-Ventures is the venture investment brand named in Think Bioscience and Aptadir financing coverage.

Recorded funding activity

Think Bioscience develops small-molecule drugs for difficult targets. Aptadir develops RNA therapeutics intended to restore expression of silenced genes. Their retained announcements establish the two investment relationships without substituting a parent corporation or an unnamed individual fund.

Sources
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$100.4M
2 disclosed · full round size, not this investor’s share

By stage

Seed1
Series A1

By primary sector

Biotech2

By country

Italy1
United States1

Rounds

2 in this selection
Think Bioscience

Develops small molecule drugs for historically challenging drug targets

$55MSeries A
Role not disclosed